BCHE and neurodegenerative disease: Therefore, both cholinesterases are pharmacologically relevant targets in neurodegenerative diseases, and current treatment includes cholinesterase inhibitors such as donepezil, galantamine, physostigmine, rivastigmine, etc. [9,10,11,12,13,14,15,16].